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Background
The prevalence of Familial Mediterranean fever (FMF) in
Armenian people is very high. Acute recurrent or chronic
arthritis are possible manifestations of FMF and differen-
tiation from juvenile idiopathic arthritis (JIA) is impor-
tant.
Aim
To study the correlation of MEFV mutations with disease
susceptibility in patients with JIA
Methods
Retrospective chart review of all patients with JIA for
MEFV mutations and JIA characteristics.
Results
MEFV analysis was available for 44/69 patients, 7/8 with
systemic onset(So) JIA and 37/61 with other types of JIA.
MEFV mutations were found in 27/44 patients tested
(61%). 3/7 patients (43%) with SoJIA had MEFV muta-
tions, all heterozygous. Of the 24/37 patients (65%) with
other forms of JIA had confirmed MEFV mutations and
12/24 had typical episodes of FMF. With colchicine in
addition to standard JIA treatment FMF episodes resolved
but they continue to have refractory arthritis. Of the 12
patients without typical FMF episodes 10 had only arthri-
tis and 2 had rare episodes of thoracic pain in addition to
the arthritis. In 9/12 patients (10 with arthritis only and 2
with thoracic pain) a heterozygous MEFV mutation was
found, in 1 patient (8%) homozygous M694V and 2
(17%) had compound heterozygous M694V/M680I
mutations.
Conclusion
In our Armenian JIA patients 61% had MEFV mutations,
more than expected. In a population with a high preva-
lence of FMF MEFV mutations should be tested in chil-
dren with JIA even in the absence of typical FMF
symptoms as chronic arthritis may be the only symptom
of FMF.
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